The healthcare industry is rapidly adopting artificial intelligence (AI) technologies, and analysts project a $125.7 billion growth by 2028 as innovations in early detection, diagnostics, and patient care transform the sector.
A report from Technavio highlighted the growing integration of AI across healthcare applications, bolstered by favourable sentiment among healthcare professionals. A recent eClinicalWorks survey revealed that 90 percent of healthcare providers view AI positively, indicating widespread acceptance of the technology’s potential to enhance healthcare delivery. The Food and Drug Administration (FDA) in the United States has cleared over 800 AI-based health applications, signalling their growing importance in clinical and diagnostic settings.
Avant Technologies, Inc., in partnership with Ainnova Tech, Inc., has secured exclusive rights to four advanced algorithms for early detection of cardiovascular risk, prediabetes, fatty liver disease, and chronic kidney disease. These AI-powered tools, validated across diverse populations and geographies, join Ainnova’s VisionAI platform to provide early, accurate disease detection.
In a statement, Vinicio Vargas, CEO of Ainnova, emphasized the significance of these algorithms in expanding access to preventive care. "This license represents a pivotal moment for Ainnova and for its partnership with Avant as it allows us to bring world-class, validated solutions to the Americas," Vargas said. Ainnova plans to introduce these solutions in Latin America with strategic partners and aims to secure FDA clearance for the US market by 2025.
Other companies are also leveraging AI to drive innovation. Teladoc Health recently launched AI-enabled features for its Virtual Sitter solution, improving patient safety and addressing workforce challenges by allowing remote staff to monitor more patients efficiently. Similarly, Butterfly Network introduced an AI-powered cardiac education app to train healthcare practitioners on essential diagnostic techniques, enhancing access to critical cardiac care.
Analysts at Market.us predict the generative AI healthcare market will reach $17.2 billion by 2032, with a compound annual growth rate of 37 percent. With applications ranging from home testing to autonomous coding, AI is expected to play a significant role in the future of healthcare systems worldwide.